Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 41.

Schmutz, C; Mäusezahl, D; Bless, P J; Hatz, C; Schwenkglenks, Matthias; Urbinello, D (2017). Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland. Epidemiology and Infection, 145(04):627-641.

Mosimann, V; Neumayr, A; Hatz, C; Blum, J A (2013). Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment. Infection, 41(6):1177-1182.

Engler, O; Klingstrom, J; Aliyev, E; Niederhauser, C; Fontana, S; Strasser, M; Portmann, J; Signer, J; Bankoul, S; Frey, F; Hatz, C; Stutz, A; Tschaggelar, A; Mütsch, Margot (2013). Seroprevalence of hantavirus infections in Switzerland in 2009: difficulties in determining prevalence in a country with low endemicity. Eurosurveillance, 18(50):20660.

Soukhathammavong, Phonepasong Ayé; Odermatt, P; Sayasone, S; Vonghachack, Y; Vounatsou, P; Hatz, C; Akkhavong, K; Keiser, J (2011). Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infectious Diseases, 11(2):110-118.

Hatz, C; Funk, M; Beck, B; Holzer, B; Blum, J; Bourquin, C; Etter, H; Furrer, H J; Genton, B; Jamnicki, B; Landry, P; Loutan, L; Schlagenhauf, Patricia; Stössel, U; de Vallière, S; Behrens, R H; Caumes, E; Jeschko, E; Nothdurft, H D; Visser, L G; Wiedermann, U (2011). Malaria update 2011. Bulletin Bundesamt für Gesundheit, (13):280-297.

Kramme, S; Marti, H; Genton, B; Hatz, C (2011). Comment la sérologie peut-elle aider à l’établissement du diagnostic des parasites? Revue Médicale Suisse, 7(294):995-999.

Becker, S L; Sieto, B; Silué, K D; Adjossan, L; Koné, S; Hatz, C; Kern, W V; N'Goran, E K; Utzinger, J (2011). Diagnosis, clinical features, and self-reported morbidity of Strongyloides stercoralis and hookworm infection in a Co-endemic setting. PLoS Neglected Tropical Diseases, 5(8):e1292.

Lang, P; Piller, U; Hatz, C (2011). Durchimpfung von 2-, 8-, und 16-jährigen Kindern in 15 Kantonen der Schweiz. Bulletin Bundesamt für Gesundheit, (49):1121-1126.

Neumayr, A; Hatz, C (2011). Eastern Africa. In: Petersen, Eskild; Chen, Lin H; Schlagenhauf, Patricia. Infectious Diseases: A Geographic Guide. Chichester, UK: Wiley-Blackwell, 64-83.

Keiser, J; Sayed, H; El-Ghanam, M; Sabry, H; Anani, S; El-Wakeel, A; Hatz, C; Utzinger, J; El-Din, S S; El-Maadawy, W; Botros, S (2011). Efficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trials. PLoS Neglected Tropical Diseases, 5(9):e1285.

Mossdorf, E; Stoeckle, M; Mwaigomole, E G; Chiweka, E; Kibatala, P L; Geubbels, E; Urassa, H; Abdulla, S; Elzi, L; Tanner, M; Furrer, H; Hatz, C; Battegay, M (2011). Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC Infectious Diseases, 11:98.

Neumayr, A; Troia, G; de Bernardis, C; Tamarozzi, F; Goblirsch, S; Piccoli, L; Hatz, C; Filice, C; Brunetti, E (2011). Justified concern or exaggerated fear: the risk of anaphylaxis in percutaneous treatment of cystic echinococcosis-a systematic literature review. PLoS Neglected Tropical Diseases, 5(6):e1154.

Hatz, C; Funk, M; Beck, B; Holzer, B; Blum, J; Bourquin, C; Etter, H; Furrer, H J; Genton, B; Jamnicki, B; Landry, P; Loutan, L; Schlagenhauf, Patricia; Stössel, U; de Vallière, S; Behrens, R H; Caumes, E; Jeschko, E; Nothdurft, H D; Visser, L; Wiedermann, U (2011). Neue Gelbfieber-Impfempfehlungen der WHO/CDC, 2011. Bulletin Bundesamt für Gesundheit, (31):651-652.

Hatz, C; Beck, B; Steffen, R; Genton, B; d'Acremont, V; Loutan, L; Hartmann, K; Herzog, C (2011). Real-life versus package insert: a post-marketing study on adverse-event rates of the virosomal hepatitis A vaccine Epaxal® in healthy travellers. Vaccine, 29(31):5000-5006.

Hatz, C; van der Ploeg, R; Beck, B R; Frösner, G; Hunter, M; Herzog, C (2011). Successful memory response following a booster dose with a virosome-formulated hepatitis a vaccine delayed up to 11 years. Clinical and Vaccine Immunology : CVI, 18(5):885-887.

Lang, P; Zimmermann, H; Piller, U; Steffen, R; Hatz, C (2011). The Swiss National Vaccination Coverage Survey, 2005-2007. Public Health Reports, 126(Sup 2):97-108.

Keiser, J; N'Guessan, N A; Adoubryn, K D; Silué, K D; Vounatsou, P; Hatz, C; Utzinger, J; N'Goran, E K (2010). Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clinical Infectious Diseases, 50(9):1205-1213.

Navarini, A A; Stoeckle, M; Navarini, S; Jullu, B; Mchomvu, R; Mbta, M; Kibatala, K; Tanner, M; Hatz, C; Schmid-Grendelmeier, P (2010). Antihistamines are superior to topical steroids in managing Human Immunodeficiency Virus (HIV)-associated papular pruritic eruption. International Journal of Dermatology, 49(1):83- 86.

Frey, S G; Chelo, D; Kinkela, M N; Djoukoue, F; Tietche, F; Hatz, C; Weber, P (2010). Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety. Malaria Journal, 9:291.

Lang, P; Piller, U; Steffen, R; Hatz, C (2010). Durchimpfung in der Schweiz 2005-2007. Bulletin Bundesamt für Gesundheit, (11):367-377.

Hatz, C; Inoubli, S; Loutan, L; Genton, B; Behrens, R; Hufnagel, M (2010). Encéphalite japonaise: risque pour les populations vivant en zones d’endémie et pour les voyageurs. Revue Médicale Suisse, 248:956-959.

Mossdorf, E; Stoeckle, M; Vincenz, A; Mwaigomole, E G; Chiweka, E; Kibatala, P; Urassa, H; Abdulla, S; Elzi, L; Tanner, M; Furrer, H; Hatz, C; Battegay, M (2010). Impact of a national HIV voluntary counselling and testing (VCT) campaign on VCT in a rural hospital in Tanzania. Tropical Medicine & International Health, 15(5):567-573.

Matteelli, A; Stauffer, W M; Barnett, E D; MacPherson, D W; Loutan, L; Hatz, C; Behrens, R H (2010). Is a new definition required for travelers who visit friends and relatives? Journal of Travel Medicine, 17(6):430-431.

Hatz, C; Funk, M; Beck, B; Holzer, B; Blum, J; Bourquin, C; Etter, H; Furrer, H J; Genton, B; Jamnicki, B; Landry, P; Loutan, L; Schlagenhauf, Patricia; Steffen, R; Stössel, U; de Vallière, S; Behrens, R H; Caumes, E; Jeschko, E; Nothdurft, H D (2010). Malaria-Update 2010. Bulletin Bundesamt für Gesundheit, (19):506-524.

Forno, C; Häusermann, P; Hatz, C; Itin, P; Blum, J (2010). The difficulty in diagnosis and treatment of leprosy. Journal of Travel Medicine, 17(4):281-283.

Behrens, R H; Carroll, B; Hellgren, U; Visser, L G; Siikamäki, H; Vestergaard, L S; Calleri, G; Jänisch, T; Myrvang, B; Gascon, J; Hatz, C (2010). The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator? Malaria Journal, 9:266.

Tietche, F; Chelo, D; Mina Ntoto, N K; Djoukoue, F M; Hatz, C; Frey, S; Frentzel, A; Trapp, S; Zielonka, R; Mueller, E A (2010). Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, 82(6):1034-1040.

Veit, O; Hatz, C; Niedrig, M; Furrer, H J (2010). Yellow fever vaccination in HIV-infected patients. HIV Therapy, 4(1):17-26.

Veit, O; Niedrig, M; Chapuis-Taillard, C; Cavassini, M; Mossdorf, E; Schmid, P; Bae, H G; Litzba, N; Staub, T; Hatz, C; Furrer, H (2009). Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clinical Infectious Diseases, 48(5):659-66.

Sayasone, S; Tesana, S; Utzinger, J; Hatz, C; Akkhavong, K; Odermatt, P (2009). Rare human infection with the trematode Echinochasmus japonicus in Lao PDR. Parasitology International, 58(1):106-109.

Saxer, F; Widmer, A; Fehr, J; Soka, I; Kibatala, P; Urassa, H; Frei, R; Smith, T; Hatz, C (2009). Benefit of a single preoperative dose of antibiotics in a sub-saharan district hospital: minimal input, massive impact. Annals of Surgery, 249(2):322-326.

Blum, J A; Schmid, C; Burri, C; Hatz, C; Olson, C; Fungula, B; Kazumba, L; Mangoni, P; Mbo, F; Deo, K; Mpanya, A; Dala, A; Franco, J; Pohlig, G; Zellweger, M J (2009). Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment. PLoS Neglected Tropical Diseases, 3(2):e383.

Blum, J; Hatz, C (2009). Dengue- und Chikungunya-Fieber in der Allgemeinpraxis. Swiss Medical Forum, 9(35):610-615.

Steffen, R; Hatz, C (2009). Hypes und Gefahren im Zeichen der Globalisierung. Hausarzt Praxis, (10):5.

Dobler, G; Frühwein, N; Hatz, C; Jelinek, T; Kaiser, R; Kollaritsch, H; Nothdurft, H D; Schönfeld, C; Steffen, R; Weiss, W; Wiedermann, U (2009). Konsensuspapier zur Prophylaxe der japanischen Enzephalitis für Reisende. MMW-Fortschritte der Medizin, 151(1):24-26.

Van Damme, P; von Sonnenburg, F; Hatz, C; Hoet, B; Lefevre, I; Leyssen, M (2009). Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults. Journal of Medical Virology, 81(10):1710-5.

Hatz, C; Funk, M; Beck, B; Holzer, B; Etter, H; Furrer, H J; Genton, B; Jamnicki, B; Landry, P; Loutan, L; Schlagenhauf, Patricia; Steffen, R (2009). Malaria Update 2009. Bulletin Bundesamt für Gesundheit, (26):457-460.

Weinke, T; Liebold, I; Burchard, G D; Frühwein, N; Grobusch, M P; Hatz, C; Kollaritsch, H; Nothdurft, H D; Reisinger, E; Rieke, B; Schönfeld, C; Steffen, R; Stich, A (2006). Prophylactic immunization against enterotoxin-forming Escherichia coli travellers' diarrhea and cholera: does it make sense and for whom? Deutsche Medizinische Wochenschrift, 131(30):1660-1664.

Gilgen, D; Maeusezahl, D; Salis Gross, Corina; Battegay, E; Flubacher, P; Tanner, M; Weiss, M G; Hatz, C (2005). Impact of migration on illness experience and help-seeking strategies of patients from Turkey and Bosnia in primary health care in Basel. Health & Place, 11(3):261-273.

Gilgen, D; Maeusezahl, D; Salis Gross, Corina; Battegay, E; Flubacher, P; Tanner, M; Weiss, M G; Hatz, C (2003). Klinische 'cultural epidemiology' von Gesundheitsproblemen ambulant behandelter Migrantinnen und Migranten aus der Türkei und aus Bosnien. In: Wicker, H-R; Fibbi, R; Haug, W. Migration und die Schweiz. Ergebnisse des Nationalen Forschungsprogramms \dqMigration und interkulturelle Beziehungen\dq. Zürich: Seismo, 507-530.

Gilgen, D; Salis Gross, Corina; Maeusezahl, D; Frey, C; Tanner, M; Weiss, M G; Hatz, C (2002). Impact of organized violence on illness experience of Turkish/Kurdish and Bosnian migrant patients in primary care. Journal of Travel Medicine, 9(5):236-243.

This list was generated on Mon Dec 18 15:40:06 2017 CET.